Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-23-004865

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 82,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2023-03-13 Grant or award · Stock Option (right to purchase) +62,000 62,000 D
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2023-03-13 Grant or award · Restricted Stock Units +20,667 20,667 D
Loading xslF345X03/form4-03142023_100352.xml…